Phoenix Pharmalabs Overview

  • Founded
  • 2002
Founded
  • Status
  • Private
  • Employees
  • 5
Employees
  • Latest Deal Type
  • Crowdfunding
  • Latest Deal Amount
  • $1.1M
Latest Deal Amount
  • Investors
  • 4

Phoenix Pharmalabs General Information

Description

Developers of drugs created to treat pain and opiate addiction. The company focuses on the development and commercialization of new non-addictive treatments, enabling people to get access to potent pain therapy without the risk of addiction and serious side effects.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Drug Discovery
Primary Office
  • 999 West 1500 South
  • 600
  • Woods Cross, UT 84087
  • United States
+1 (860) 000-0000

Phoenix Pharmalabs Timeline

2017201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Phoenix Pharmalabs Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Equity Crowdfunding 08-Apr-2019 $1.1M 00000 Completed Pre-Clinical Trials
4. Grant 01-Jan-2018 00.000 00000 Completed Pre-Clinical Trials
3. Grant 01-Jan-2011 00000 00000 Completed Startup
2. Angel (individual) 01-Jan-2011 $270K $270K Completed Startup
1. Grant 01-Jan-2004 $100K Completed Startup
To view Phoenix Pharmalabs’s complete valuation and funding history, request access »

Phoenix Pharmalabs Executive Team (5)

Name Title Board Seat Contact Info
William Crossman Board Member, Chief Executive Officer & President
John Lawson Ph.D Co-Founder, Chairman & Chief Scientific Officer
Lawrence Toll Ph.D Co-Founder, Board Member & Chief Neuropharmacologist
Chris Tew Board Member & Vice President
Timmy Chou Board Member, Chief Education Officer & Vice President
To view Phoenix Pharmalabs’s complete executive team members history, request access »

Phoenix Pharmalabs Board Members (5)

Name Representing Role Since
Chris Tew Phoenix Pharmalabs Board Member & Vice President 000 0000
John Lawson Ph.D Phoenix Pharmalabs Co-Founder, Chairman & Chief Scientific Officer 000 0000
Lawrence Toll Ph.D Phoenix Pharmalabs Co-Founder, Board Member & Chief Neuropharmacologist 000 0000
Timmy Chou Self Board Member, Chief Education Officer & Vice President 000 0000
William Crossman Phoenix Pharmalabs Board Member, Chief Executive Officer & President 000 0000
To view Phoenix Pharmalabs’s complete board members history, request access »

Phoenix Pharmalabs Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Phoenix Pharmalabs Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institutes of Health Government 000 0000 000000 0
United States Department of Defense Government 000 0000 000000 0
National Institute on Drug Abuse (NIDA) Other 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
To view Phoenix Pharmalabs’s complete investors history, request access »